T. Rowe Price Associates’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $118K | Buy |
95,291
+30,514
| +47% | +$37.8K | ﹤0.01% | 2860 |
|
|
2025
Q1 | $72K | Hold |
64,777
| – | – | ﹤0.01% | 2877 |
|
|
2024
Q4 | $59K | Sell |
64,777
-6,369,269
| -99% | -$5.8M | ﹤0.01% | 2901 |
|
|
2024
Q3 | $6.35M | Buy |
6,434,046
+939,252
| +17% | +$927K | ﹤0.01% | 1232 |
|
|
2024
Q2 | $4.95M | Buy |
5,494,794
+2,603,789
| +90% | +$2.34M | ﹤0.01% | 1229 |
|
|
2024
Q1 | $3.41M | Sell |
2,891,005
-804,222
| -22% | -$949K | ﹤0.01% | 1339 |
|
|
2023
Q4 | $3.37M | Buy |
+3,695,227
| New | +$3.37M | ﹤0.01% | 1328 |
|
|
2023
Q3 | – | Sell |
-1,318,680
| Closed | -$1.58M | – | 2894 |
|
|
2023
Q2 | $1.58M | Buy |
1,318,680
+244,150
| +23% | +$293K | ﹤0.01% | 1571 |
|
|
2023
Q1 | $1.36M | Sell |
1,074,530
-234,277
| -18% | -$295K | ﹤0.01% | 1634 |
|
|
2022
Q4 | $2.84M | Buy |
1,308,807
+1,298,783
| +12,957% | +$2.82M | ﹤0.01% | 1346 |
|
|
2022
Q3 | $121K | Buy |
+10,024
| New | +$121K | ﹤0.01% | 2683 |
|